Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo

Stem Cell Research

Volumn 6, Issue 1, 2011, Pages 50-59

  Moon, Sung Hwan ^a   Kim, Jong Soo ^b   Park, Soon Jung ^b   Lim, Joa Jin ^b   Lee, Hye Jin ^b   Lee, Seon Moo ^c   Chung, Hyung Min ^a,b  

^a CHA Stem Cell Institute   (South Korea)

^b CHA University   (South Korea)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CHROMOSOMAL INSTABILITY; CHROMOSOME 12; CONTROLLED STUDY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINDLE CELL; STEM CELL TRANSPLANTATION; TERATOMA; TRISOMY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; EMBRYONIC STEM CELLS; HUMANS; KARYOTYPING; MALE; MICE; MICE, NUDE;

MUS;

EID: 78649519470     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.08.006     Document Type: Article

References (38)

1. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
2. Bernatchez P.N., Soker S., Sirois M.G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J. Biol. Chem. 1999, 274:31047-31054.
3. Braam S.R., Denning C., van den Brink S., Kats P., Hochstenbach R., Passier R., et al. Improved genetic manipulation of human embryonic stem cells. Nat. Meth. 2008, 5:389-392.
4. Brazelton T.R., Blau H.M. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 2005, 23:1251-1265.
5. Brinkley B.R., Goepfert T.M. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motil. Cytoskeleton 1998, 41:281-288.
6. Buzzard J.J., Gough N.M., Crook J.M., Colman A. Karyotype of human ES cells during extended culture. Nat. Biotechnol. 2004, 22:381-382. author reply 382.
7. Cao F., Wagner R.A., Wilson K.D., Xie X., Fu J.D., Drukker M., et al. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE 2008, 3:e3474.
8. Chen J.G., Horwitz S.B. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res. 2002, 62:1935-1938.
9. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
10. Clark A.T., Rodriguez R.T., Bodnar M.S., Abeyta M.J., Cedars M.I., Turek P.J., et al. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 2004, 22:169-179.
11. Cross J.C., Werb Z., Fisher S.J. Implantation and the placenta: key pieces of the development puzzle. Science 1994, 266:1508-1518.
12. D'Assoro A.B., Lingle W.L., Salisbury J.L. Centrosome amplification and the development of cancer. Oncogene 2002, 21:6146-6153.
13. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004, 22:53-54.
14. Dutrillaux B., Viegas-Pequignot E. High resolution R- and G-banding on the same preparation. Hum. Genet. 1981, 57:93-95.
15. Ganem N.J., Godinho S.A., Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282.
16. Gao C., Furge K., Koeman J., Dykema K., Su Y., Cutler M.L., et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc. Natl Acad. Sci. USA 2007, 104:8995-9000.
17. Gertow K., Cedervall J., Unger C., Szoke K., Blennow E., Imreh M.P., et al. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J. Cell. Biochem. 2007, 100:1518-1525.
18. Ilagan R., Pottratz J., Le K., Zhang L., Wong S.G., Ayala R., et al. Imaging mitogen-activated protein kinase function in xenograft models of prostate cancer. Cancer Res. 2006, 66:10778-10785.
19. Kim S., Kim G.J., Miyoshi H., Moon S.H., Ahn S.E., Lee J.H., et al. Efficiency of the elongation factor-1alpha promoter in mammalian embryonic stem cells using lentiviral gene delivery systems. Stem Cells Dev. 2007, 16:537-545.
20. Kim J., Moon S.H., Lee S.H., Lee D.R., Koh G.Y., Chung H.M. Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells. Stem Cells Dev. 2007, 16:269-280.
21. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
22. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature 1997, 386:623-627.
23. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., Langer R. Endothelial cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 2002, 99:4391-4396.
24. Li Z., Suzuki Y., Huang M., Cao F., Xie X., Connolly A.J., et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 2008, 26:864-873.
25. Lu S.J., Feng Q., Caballero S., Chen Y., Moore M.A., Grant M.B., et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat. Meth. 2007, 4:501-509.
26. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2002, 2:815-825.
27. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
28. Pawelczyk E., Arbab A.S., Chaudhry A., Balakumaran A., Robey P.G., Frank J.A. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells 2008, 26:1366-1375.
29. Rajagopalan H., Lengauer C. Aneuploidy and cancer. Nature 2004, 432:338-341.
30. Sluder G., Nordberg J.J. The good, the bad and the ugly: the practical consequences of centrosome amplification. Curr. Opin. Cell Biol. 2004, 16:49-54.
31. Sluder G., Thompson E.A., Miller F.J., Hayes J., Rieder C.L. The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. J. Cell Sci. 1997, 110(Pt 4):421-429.
32. Swenson E.S., Price J.G., Brazelton T., Krause D.S. Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 2007, 25:2593-2600.
33. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
34. van der Bogt K.E., Swijnenburg R.J., Cao F., Wu J.C. Molecular imaging of human embryonic stem cells: keeping an eye on differentiation, tumorigenicity and immunogenicity. Cell Cycle 2006, 5:2748-2752.
35. Wang Z.Z., Au P., Chen T., Shao Y., Daheron L.M., Bai H., et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 2007, 25:317-318.
36. Weaver B.A., Silk A.D., Montagna C., Verdier-Pinard P., Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007, 11:25-36.
37. Yang S., Lin G., Tan Y.Q., Zhou D., Deng L.Y., Cheng D.H., et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosom. Cancer 2008, 47:665-679.
38. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+embryonic-stem-cell-derived population. Nature 2008, 453:524-528.